These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38831092)
1. MNT inhibits lung adenocarcinoma ferroptosis and chemosensitivity by suppressing SAT1. Zhao G; Liang J; Zhang Y; Shan G; Bian Y; Gu J; Zhan C; Ge D Commun Biol; 2024 Jun; 7(1):680. PubMed ID: 38831092 [TBL] [Abstract][Full Text] [Related]
2. Retinoic acid receptor alpha inhibits ferroptosis by promoting thioredoxin and protein phosphatase 1F in lung adenocarcinoma. Bian Y; Shan G; Liang J; Hu Z; Sui Q; Shi H; Wang Q; Bi G; Zhan C Commun Biol; 2024 Jun; 7(1):751. PubMed ID: 38902322 [TBL] [Abstract][Full Text] [Related]
3. LRP1B Suppresses Immunotherapy Efficacy in Lung Adenocarcinoma by Preventing Ferroptosis. Ke ZH; Chen Y; Yu T; Zhang Q; Xiang Y; Lu KH Cancer Med; 2024 Dec; 13(23):e70486. PubMed ID: 39660409 [TBL] [Abstract][Full Text] [Related]
4. Transcription Factor E2F8 Activates PDK1-Mediated DNA Damage Repair to Enhance Cisplatin Resistance in Lung Adenocarcinoma. Li H; Sun J; Hu H; Wang Y Pharmacology; 2024; 109(6):341-356. PubMed ID: 38810606 [TBL] [Abstract][Full Text] [Related]
5. Corosolic acid inhibits EMT in lung cancer cells by promoting YAP-mediated ferroptosis. Zhang C; Gao L; Zhang Y; Jin X; Wang M; Wang Q; Zhao W; Wu N; Zhang Y; Liu Y; Zhang Y; Ma L; Chen Y Phytomedicine; 2024 Dec; 135():156110. PubMed ID: 39369568 [TBL] [Abstract][Full Text] [Related]
6. IGF2BP2 promotes lung adenocarcinoma progression by regulating LOX1 and tumor-associated neutrophils. Qian L; Ji Z; Mei L; Zhao J Immunol Res; 2024 Dec; 73(1):16. PubMed ID: 39688738 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Sat1 alleviates myocardial ischemia-reperfusion injury through regulation of ferroptosis via MAPK/ERK pathway. Liu Z; Chen H; Song Y; Chen K; Pan S; Yang S; Lu D Front Pharmacol; 2024; 15():1476718. PubMed ID: 39605920 [TBL] [Abstract][Full Text] [Related]
8. Transcription factor NFYA inhibits ferroptosis in lung adenocarcinoma cells by regulating PEBP1. Chen F; Xu T; Jin N; Li D; Ying Y; Wang C Mutat Res; 2024; 829():111873. PubMed ID: 38996537 [TBL] [Abstract][Full Text] [Related]
9. TFAP2A Promotes Cell Progression and Suppresses Ferroptosis in Lung Adenocarcinoma via Activating Transcription of CST1. Luan X; Peng X; Hui G; Wei Z J Biochem Mol Toxicol; 2025 Jan; 39(1):e70087. PubMed ID: 39692484 [TBL] [Abstract][Full Text] [Related]
10. ZNF131-BACH1 transcriptionally accelerates RAD51-dependent homologous recombination repair and therapy-resistance of non-small-lung cancer cells by preventing their degradation from CUL3. Fan M; Liu Q; Ma X; Jiang Y; Wang Y; Jia S; Nie Y; Deng R; Zhou P; Zhang S; Jiang S; Guan M; Hou Y; Miao Y; Zhang Y; Zhang X Theranostics; 2024; 14(18):7241-7264. PubMed ID: 39629137 [No Abstract] [Full Text] [Related]
11. Enhancing lobaplatin sensitivity in lung adenocarcinoma through inhibiting LDHA-targeted metabolic pathways. Yuan S; Ou W; Mi X; Hou J PLoS One; 2024; 19(12):e0310825. PubMed ID: 39680520 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of TNFSF11 reduces GPX4 levels and increases sensitivity to ferroptosis inducers in lung adenocarcinoma. Li Z; Lu W; Yin F; Zeng P; Li H; Huang A J Transl Med; 2024 Apr; 22(1):340. PubMed ID: 38594779 [TBL] [Abstract][Full Text] [Related]
13. CHAC1 blockade suppresses progression of lung adenocarcinoma by interfering with glucose metabolism via hijacking PKM2 nuclear translocation. Pan J; Wu S; Pan Q; Zhang Y; He L; Yao Q; Chen J; Li J; Xu Y Cell Death Dis; 2024 Oct; 15(10):728. PubMed ID: 39368995 [TBL] [Abstract][Full Text] [Related]
14. Decreased lncRNA HNF4A-AS1 facilitates resistance to sorafenib-induced ferroptosis of hepatocellular carcinoma by reprogramming lipid metabolism. Zhao Y; Han S; Zeng Z; Zheng H; Li Y; Wang F; Huang Y; Zhao Y; Zhuo W; Lv G; Wang H; Zhao G; Zhao E; Hu Y; Hu P; Zhao G Theranostics; 2024; 14(18):7088-7110. PubMed ID: 39629121 [No Abstract] [Full Text] [Related]
15. Long Non-Coding RNA LINC01116 Promotes the Proliferation of Lung Adenocarcinoma by Targeting miR-9-5p/CCNE1 Axis. Zhang H; Cai W; Miao Y; Gu Y; Zhou X; Kaneda H; Wang L J Cell Mol Med; 2024 Dec; 28(23):e70270. PubMed ID: 39648148 [TBL] [Abstract][Full Text] [Related]
16. Erianin inhibits the progression of DDP-resistant lung adenocarcinoma by regulating the Wnt/β-catenin pathway and activating the caspase-3 for apoptosis in vitro and in vivo. Tang L; Ruan Y; Wang B; Zhang M; Xue J; Wang T Hereditas; 2024 Nov; 161(1):48. PubMed ID: 39605083 [TBL] [Abstract][Full Text] [Related]
17. Suppressing GDF15 enhances the chemotherapeutic effect of 5 FU on MSI-H CRC by regulating the ferroptosis pathway SLC7A11/GSH/GPX4. Huang Fu ZM; Xiao M; Xie H; Zhang S; Yi T; Li Q; Li M; Wang Y J Cancer Res Clin Oncol; 2024 Dec; 151(1):6. PubMed ID: 39636345 [TBL] [Abstract][Full Text] [Related]
18. [GINS1 Enhances Glycolysis, Proliferation and Metastasis in Lung Adenocarcinoma Cells by Activating the Notch/PI3K/AKT/mTORC1 Signaling Pathway]. Huo Y; Xu X; Ma X; Feng Y Zhongguo Fei Ai Za Zhi; 2024 Oct; 27(10):735-744. PubMed ID: 39631830 [TBL] [Abstract][Full Text] [Related]
19. ANP32E promotes esophageal cancer progression and paclitaxel resistance via P53/SLC7A11 axis-regulated ferroptosis. Sun LY; Ke SB; Li BX; Chen FS; Huang ZQ; Li L; Zhang JF; Cai YX; Zhu HJ; Zhang XD; Du RL; Liu Y; Chen YS Int Immunopharmacol; 2025 Jan; 144():113436. PubMed ID: 39566382 [TBL] [Abstract][Full Text] [Related]